POLITICO
Get the POLITICO Pulse newsletter
Email
Sign Up
By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Presented by the Pharmaceutical Care Management Association
With Rachel Roubein, Alice Miranda Ollstein, Susannah Luthi, Dan Goldberg, Joanne Kenen and Daniel Lippman
Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care s morning newsletter, which is delivered to our subscribers each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day’s biggest stories.
To print this article, all you need is to be registered or login on Mondaq.com.
Five months after the Supreme Court of the United States handed down a loss to the pharmacy
benefit manager (PBM) lobbying group Pharmaceutical Care Management
Association (PCMA), PCMA filed a brief in the Eighth Circuit
arguing that the Court s ruling does not narrow the scope of
Employee Retirement Income Security Act (ERISA) preemption for PBM
regulation.
On December 10, 2020, the Supreme Court, in
Rutledge v.
Pharmaceutical Care Management Association, ruled that an
Arkansas law prohibiting PBMs from reimbursing pharmacies for drugs
at rates below the drugs acquisition costs was not preempted
POLITICO
Get the Prescription Pulse newsletter
Email
Sign Up
By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Presented by Pharmaceutical Care Management Association
With Lauren Morello, Lauraine Genota, Emily Martin and Sarah Owermohle.
On Tap CDC’s vaccine advisory committee is set to weigh Pfizer’s shot for young teens next week. More data are demonstrating Covid-19 vaccines are highly effective in the real world.